|
PPARA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77302617032637E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.35980116056089E-11 |
| Normal-vs-Stage2 |
3.178000E-04 |
| Normal-vs-Stage3 |
4.40092406961412E-13 |
| Normal-vs-Stage4 |
5.08770026108607E-10 |
| Stage1-vs-Stage2 |
3.812000E-01 |
| Stage1-vs-Stage3 |
9.593700E-02 |
| Stage1-vs-Stage4 |
1.132170E-01 |
| Stage2-vs-Stage3 |
8.414300E-02 |
| Stage2-vs-Stage4 |
7.070000E-02 |
| Stage3-vs-Stage4 |
7.335600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.29705143794945E-13 |
| Normal-vs-AfricanAmerican |
9.72209999949847E-07 |
| Normal-vs-Asian |
6.43160000035614E-07 |
| Caucasian-vs-AfricanAmerican |
4.916600E-01 |
| Caucasian-vs-Asian |
8.997400E-01 |
| AfricanAmerican-vs-Asian |
6.461800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.87279985858413E-10 |
| Normal-vs-Female |
2.06812345027174E-12 |
| Male-vs-Female |
8.431000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.29819999195036E-09 |
| Normal-vs-Age(41-60Yrs) |
2.77555756156289E-14 |
| Normal-vs-Age(61-80Yrs) |
2.72210000096251E-08 |
| Normal-vs-Age(81-100Yrs) |
1.500380E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.957560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.961800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.067000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.384000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.863200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.427600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.301200E-01 |
| Classical-VS-Follicular |
3.439200E-01 |
| Classical-VS-Other |
2.389200E-01 |
| Classical-VS-Normal |
1.11759490550867E-11 |
| Tall-VS-Follicular |
6.539400E-01 |
| Tall-VS-Other |
5.635600E-01 |
| Tall-VS-Normal |
2.43729999516162E-08 |
| Follicular-VS-Other |
5.169600E-01 |
| Follicular-VS-Normal |
2.39830000303698E-08 |
| Other-VS-Normal |
1.056620E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.21913631704274E-12 |
| Normal-vs-N1 |
7.90929988170319E-10 |
| N0-vs-N1 |
2.272600E-01 |
|
|
